Alvimopan for recovery of bowel function after radical cystectomy

Keyphrases

• Alvimopan 100%
• Radical Cystectomy 100%
• Bowel Function 100%
• Confidence Interval 58%
• Risk Ratio 33%
• Major Adverse Events 25%
• Enhanced Recovery Program 25%
• Narcotics 16%
• Hazard Ratio 16%
• Hospital Discharge 16%
• Parenteral nutrition 16%
• MEDLINE 16%
• Embase 16%
• Urinary Diversion 16%
• Risk of Bias 16%
• Solid Food 16%
• Day of Surgery 16%
• Nasogastric Tube 16%
• Risk Reduction 8%
• Placebo 8%
• Randomized Controlled Trial 8%
• Cardiovascular Risk 8%
• Postoperative Ileus 8%
• Subgroup Analysis 8%
• Abdominal Surgery 8%
• Cardiovascular Events 8%
• Urologic 8%
• Table-driven 8%
• Event Risk 8%
• Adverse Events 8%
• Postoperative Day 8%
• Sensitivity Analysis 8%
• Multiple Databases 8%
• American Society of Clinical Oncology 8%
• Cochrane 8%
• Search Methods 8%
• Readmission Risk 8%
• Cystectomy 8%
• Cochrane Library 8%
• Result-oriented 8%
• Small Bowel Resection 8%
• Primary Anastomosis 8%
• Selection Criteria 8%
• Trial Registries 8%
• Composite Endpoint 8%
• Comprehensive Search 8%
• Web of Science 8%
• Scopus 8%
• Cochrane Central Register of Controlled Trials 8%
• Bowel Movement 8%
• Intention-to-treat Analysis 8%
• Bowel Dysfunction 8%
• Urologic Oncology 8%
• Summary of Findings Table 8%
• Reinsertion 8%
• Pain Medication Use 8%
• Genitourinary Cancer 8%
• Drug Manufacturer 8%
• Readmission Rates 8%
• Medical Experts 8%
• Morphine Equivalents 8%

Medicine and Dentistry

• Cystectomy 100%
• Intestine Function 100%
• Alvimopan 100%
• Adverse Event 33%
• Cardiovascular System 16%
• Hazard Ratio 16%
• Parenteral Nutrition 16%
• Independent Reviewer 16%
• Urinary Diversion 16%
• Day of Surgery 16%
• Drug Therapy 8%
• Subgroup Analysis 8%
• Randomized Controlled Trial 8%
• Clinical Oncology 8%
• Surgical Anastomosis 8%
• Intention-to-Treat Analysis 8%
• Digestive System Surgery 8%
• Small Intestine Resection 8%
• Urologic Oncology 8%
• Postoperative Ileus 8%
• Placebo 8%
• Urogenital Tract Cancer 8%
• Morphine 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Alvimopan 100%
• Adverse Event 33%
• Narcotic Agent 16%
• Randomized Controlled Trial 8%
• Pharmaceutical Manufacturing 8%
• Placebo 8%
• Postoperative Ileus 8%
• Urogenital Tract Cancer 8%
• Morphine 8%